The PE Ratio as of November 2024 (TTM) for Marker Therapeutics, Inc. (MRKR) is -2.90

According to Marker Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.90. This represents a change of -31.57% compared to the average of -4.24 of the last 4 quarters.

Marker Therapeutics, Inc. (MRKR) Historical PE Ratio (quarterly & annually)

How has MRKR PE Ratio performed in the past?

The mean historical PE Ratio of Marker Therapeutics, Inc. over the last ten years is -3.07. The current -2.90 PE Ratio has changed 9.36% with respect to the historical average. Over the past ten years (40 quarters), MRKR's PE Ratio was at its highest in in the October 2015 quarter at 2.93. The PE Ratio was at its lowest in in the June 2019 quarter at -16.48.

Marker Therapeutics, Inc. (MRKR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Marker Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Marker Therapeutics, Inc. (MRKR) Average PE Ratio

How has MRKR PE Ratio performed in the past?

The current PE Ratio of Marker Therapeutics, Inc. (MRKR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Marker Therapeutics, Inc. (MRKR) PE Ratio vs. Peers

How is MRKR’s PE Ratio compared to its peers?

Marker Therapeutics, Inc.’s PE Ratio is less than Lumos Pharma, Inc. (-1.03), greater than Exicure, Inc. (-8.71), less than Protagenic Therapeutics, Inc. (-0.52), less than PMV Pharmaceuticals, Inc. (-1.61), greater than Anebulo Pharmaceuticals, Inc. (-4.78), greater than Miromatrix Medical Inc. (-7.13), greater than ZIVO Bioscience, Inc. (-5.20), less than Bionomics Limited (-0.22), less than Agenus Inc. (-0.32), greater than Icosavax, Inc. (-15.78), less than Galera Therapeutics, Inc. (-0.07), greater than Edgewise Therapeutics, Inc. (-24.30), greater than RenovoRx, Inc. (-3.51), less than Tempest Therapeutics, Inc. (-0.66), less than Ikena Oncology, Inc. (-1.38), greater than Catalyst Biosciences, Inc. (-4.80), greater than Acrivon Therapeutics, Inc. Common Stock (-3.24), less than Alector, Inc. (-2.40), less than Aadi Bioscience, Inc. (-1.01), greater than Keros Therapeutics, Inc. (-11.12), less than Aerovate Therapeutics, Inc. (-0.91),

Build a custom stock screener for Marker Therapeutics, Inc. (MRKR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marker Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marker Therapeutics, Inc. (MRKR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marker Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.